Does mismatch negativity have utility for NMDA receptor drug development in depression?BRAZILIAN JOURNAL OF PSYCHIATRYIF2.62022-02-015OAAI
Identification of an optimal dose of intravenous ketamine for late-life treatment-resistant depression: a Bayesian adaptive randomization trialNEUROPSYCHOPHARMACOLOGYIF7.12021-11-2719OAAI
Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results Froma Randomized Controlled TrialAMERICAN JOURNAL OF PSYCHIATRYIF14.72021-05-0144OA
A randomized cross-over trial to define neurophysiological correlates of AV-101 N-methyl-d-aspartate receptor blockade in healthy veteransNEUROPSYCHOPHARMACOLOGYIF7.12020-12-1413OAAI
A Proof-of-Mechanism Study to Test Effects of the NMDA Receptor Antagonist Lanicemine on Behavioral Sensitization in Individuals With Symptoms of PTSDFRONTIERS IN PSYCHIATRYIF3.22019-12-1316OAAI
Bayesian adaptive randomization trial of intravenous ketamine for veterans with late-life, treatment-resistant depressioncontemporary clinical trialsIF1.42019-12-019OAAI
Childhood Trauma and Impulsivity in Adult Mood and Anxiety Disorders: Evidence of Behavioral Sensitization?BIOLOGICAL PSYCHIATRYIF92017-05-010PREAI
The relationship between sleep and drug use characteristics in participants with cocaine or methamphetamine use disordersPSYCHIATRY RESEARCHIF3.92014-10-0144OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向